Federal Register / Vol. 87, No. 63 / Friday, April 1, 2022 / Notices 19169 

Follow the online instructions for 

accessing the docket or go to the Docket 

Operations in Room W12–140 of the 

West Building Ground Floor at 1200 

New Jersey Avenue SE, Washington, DC 

20590–0001, between 9 a.m. and 5 p.m., 

Monday through Friday, except Federal 

holidays. 

FOR FURTHER INFORMATION CONTACT: 

Tiffany Jackson 202–267–3796, Office of 

Rulemaking, Federal Aviation 

Administration, 800 Independence 

Avenue SW, Washington, DC 20591. 

This notice is published pursuant to 

14 CFR 11.85. 

Issued in Washington, DC. 

Timothy R. Adams, 

Executive Deputy Director, Office of 

Rulemaking. 

Petition for Exemption 

Docket No.: FAA–2021–1044. 

Petitioner: Central Plains Agronomy. 

Section(s) of 14 CFR Affected: §§ 61.3 

(a)(1)(i), 91.7(a), 91.119(c), 91.121, 

91.151(b), 91.403(b), 91.405(a), 

91.407(a)(1), 91.409(a)(1) and (2), 

91.417(a) and (b), 137.19(c), (d), 

(e)(2)(ii)(iii), and (v), 137.31, 137.33, 

137.41(c), and 137.42. 

Description of Relief Sought: Central 

Plains Agronomy, LLC requests an 

exemption for the purpose of 

simultaneously operating no more than 

two DJI Agras T–20 Unmanned Aircraft 

Systems (UAS), weighing over 55 

pounds but no more than 100.75 

pounds, closer than 500 feet from 

vehicles, vessels, and structures to 

provide agricultural-related services in 

the United States. 

[FR Doc. 2022–06838 Filed 3–31–22; 8:45 am] 

BILLING CODE 4910–13–P 

DEPARTMENT OF TRANSPORTATION 

Federal Motor Carrier Safety 

Administration 

[Docket No. FMCSA–2022–0042] 

Qualification of Drivers; Exemption 

Applications; Epilepsy and Seizure 

Disorders 

AGENCY: Federal Motor Carrier Safety 

Administration (FMCSA), Department 

of Transportation (DOT). 

ACTION: Notice of applications for 

exemption; request for comments. 

SUMMARY: FMCSA announces receipt of 

applications from eight individuals for 

an exemption from the prohibition in 

the Federal Motor Carrier Safety 

Regulations (FMCSRs) against persons 

with a clinical diagnosis of epilepsy or 

any other condition that is likely to 

cause a loss of consciousness or any loss 

of ability to control a commercial motor 

vehicle (CMV) to drive in interstate 

commerce. If granted, the exemptions 

would enable these individuals who 

have had one or more seizures and are 

taking anti-seizure medication to 

operate CMVs in interstate commerce. 

DATES: Comments must be received on 

or before May 2, 2022. 

ADDRESSES: You may submit comments 

identified by the Federal Docket 

Management System (FDMS) Docket No. 

FMCSA–2022–0042 using any of the 

following methods: 

• Federal eRulemaking Portal: Go to 

www.regulations.gov/, insert the docket 

number, FMCSA–2022–0042, in the 

keyword box, and click ‘‘Search.’’ Next, 

sort the results by ‘‘Posted (NewerOlder),’’ choose the first notice listed, 

and click on the ‘‘Comment’’ button. 

Follow the online instructions for 

submitting comments. 

• Mail: Dockets Operations; U.S. 

Department of Transportation, 1200 

New Jersey Avenue SE, West Building 

Ground Floor, Room W12–140, 

Washington, DC 20590–0001. 

• Hand Delivery: West Building 

Ground Floor, Room W12–140, 1200 

New Jersey Avenue SE, Washington, 

DC, 20590–0001 between 9 a.m. and 5 

p.m., ET, Monday through Friday, 

except Federal Holidays. 

• Fax: (202) 493–2251. 

To avoid duplication, please use only 

one of these four methods. See the 

‘‘Public Participation’’ portion of the 

SUPPLEMENTARY INFORMATION section for 

instructions on submitting comments. 

FOR FURTHER INFORMATION CONTACT: Ms. 

Christine A. Hydock, Chief, Medical 

Programs Division, (202) 366–4001, 

fmcsamedical@dot.gov, FMCSA, DOT, 

1200 New Jersey Avenue SE, Room 

W64–224, Washington, DC 20590–0001. 

Office hours are 8:30 a.m. to 5 p.m., ET, 

Monday through Friday, except Federal 

holidays. If you have questions 

regarding viewing or submitting 

material to the docket, contact Dockets 

Operations, (202) 366–9826. 

SUPPLEMENTARY INFORMATION: 

I. Public Participation 

A. Submitting Comments 

If you submit a comment, please 

include the docket number for this 

notice (Docket No. FMCSA–2022–0042), 

indicate the specific section of this 

document to which each comment 

applies, and provide a reason for each 

suggestion or recommendation. You 

may submit your comments and 

material online or by fax, mail, or hand 

delivery, but please use only one of 

these means. FMCSA recommends that 

you include your name and a mailing 

address, an email address, or a phone 

number in the body of your document 

so that FMCSA can contact you if there 

are questions regarding your 

submission. 

To submit your comment online, go to 

www.regulations.gov/docket?D=FMCSA2022-0042. Next, sort the results by 

‘‘Posted (Newer-Older),’’ choose the first 

notice listed, click the ‘‘Comment’’ 

button, and type your comment into the 

text box on the following screen. Choose 

whether you are submitting your 

comment as an individual or on behalf 

of a third party and then submit. 

If you submit your comments by mail 

or hand delivery, submit them in an 

unbound format, no larger than 81⁄2 by 

11 inches, suitable for copying and 

electronic filing. If you submit 

comments by mail and would like to 

know that they reached the facility, 

please enclose a stamped, self-addressed 

postcard or envelope. 

FMCSA will consider all comments 

and material received during the 

comment period. 

B. Viewing Comments 

To view comments go to 

www.regulations.gov. Insert the docket 

number, FMCSA–2022–0042, in the 

keyword box, and click ‘‘Search.’’ Next, 

sort the results by ‘‘Posted (NewerOlder),’’ choose the first notice listed, 

and click ‘‘Browse Comments.’’ If you 

do not have access to the internet, you 

may view the docket online by visiting 

Dockets Operations in Room W12–140 

on the ground floor of the DOT West 

Building, 1200 New Jersey Avenue SE, 

Washington, DC 20590–0001, between 9 

a.m. and 5 p.m., ET, Monday through 

Friday, except Federal holidays. To be 

sure someone is there to help you, 

please call (202) 366–9317 or (202) 366– 

9826 before visiting Dockets Operations. 

C. Privacy Act 

In accordance with 49 U.S.C. 

31315(b)(6), DOT solicits comments 

from the public on the exemption 

request. DOT posts these comments, 

without edit, including any personal 

information the commenter provides, to 

www.regulations.gov, as described in 

the system of records notice (DOT/ALL– 

14 FDMS), which can be reviewed at 

www.dot.gov/privacy. 

II. Background 

Under 49 U.S.C. 31136(e) and 

31315(b), FMCSA may grant an 

exemption from the FMCSRs for no 

longer than a 5-year period if it finds 

such exemption would likely achieve a 

level of safety that is equivalent to, or 


lotter on DSK11XQN23PROD with NOTICES1
19170 Federal Register / Vol. 87, No. 63 / Friday, April 1, 2022 / Notices 

1These criteria may be found in APPENDIX A TO 

PART 391—MEDICAL ADVISORY CRITERIA, 

section H. Epilepsy: § 391.41(b)(8), paragraphs 3, 4, 

and 5, which is available on the internet at https:// 

www.gpo.gov/fdsys/pkg/CFR-2015-title49-vol5/pdf/ 

CFR-2015-title49-vol5-part391-appA.pdf. 

greater than, the level that would be 

achieved absent such exemption. The 

statute also allows the Agency to renew 

exemptions at the end of the 5-year 

period. FMCSA grants medical 

exemptions from the FMCSRs for a 2- 

year period to align with the maximum 

duration of a driver’s medical 

certification. 

The eight individuals listed in this 

notice have requested an exemption 

from the epilepsy and seizure disorders 

prohibition in 49 CFR 391.41(b)(8). 

Accordingly, the Agency will evaluate 

the qualifications of each applicant to 

determine whether granting the 

exemption will achieve the required 

level of safety mandated by statute. 

The physical qualification standard 

for drivers regarding epilepsy found in 

§ 391.41(b)(8) states that a person is 

physically qualified to drive a CMV if 

that person has no established medical 

history or clinical diagnosis of epilepsy 

or any other condition which is likely 

to cause the loss of consciousness or any 

loss of ability to control a CMV. 

In addition to the regulations, FMCSA 

has published advisory criteria 1 to 

assist medical examiners (MEs) in 

determining whether drivers with 

certain medical conditions are qualified 

to operate a CMV in interstate 

commerce. 

The criteria states that if an individual 

has had a sudden episode of a nonepileptic seizure or loss of 

consciousness of unknown cause that 

did not require anti-seizure medication, 

the decision whether that person’s 

condition is likely to cause the loss of 

consciousness or loss of ability to 

control a CMV should be made on an 

individual basis by the ME in 

consultation with the treating physician. 

Before certification is considered, it is 

suggested that a 6-month waiting period 

elapse from the time of the episode. 

Following the waiting period, it is 

suggested that the individual have a 

complete neurological examination. If 

the results of the examination are 

negative and anti-seizure medication is 

not required, then the driver may be 

qualified. 

In those individual cases where a 

driver has had a seizure or an episode 

of loss of consciousness that resulted 

from a known medical condition (e.g., 

drug reaction, high temperature, acute 

infectious disease, dehydration, or acute 

metabolic disturbance), certification 

should be deferred until the driver has 

recovered fully from that condition, has 

no existing residual complications, and 

is not taking anti-seizure medication. 

Drivers who have a history of 

epilepsy/seizures, off anti-seizure 

medication and seizure-free for 10 years, 

may be qualified to operate a CMV in 

interstate commerce. Interstate drivers 

with a history of a single unprovoked 

seizure may be qualified to drive a CMV 

in interstate commerce if seizure-free 

and off anti-seizure medication for a 5- 

year period or more. 

As a result of MEs misinterpreting 

advisory criteria as regulation, 

numerous drivers have been prohibited 

from operating a CMV in interstate 

commerce based on the fact that they 

have had one or more seizures and are 

taking anti-seizure medication, rather 

than an individual analysis of their 

circumstances by a qualified ME based 

on the physical qualification standards 

and medical best practices. 

On January 15, 2013, FMCSA 

announced in a Notice of Final 

Disposition titled, ‘‘Qualification of 

Drivers; Exemption Applications; 

Epilepsy and Seizure Disorders,’’ (78 FR 

3069), its decision to grant requests from 

22 individuals for exemptions from the 

regulatory requirement that interstate 

CMV drivers have ‘‘no established 

medical history or clinical diagnosis of 

epilepsy or any other condition which 

is likely to cause loss of consciousness 

or any loss of ability to control a CMV.’’ 

Since that time, the Agency has 

published additional notices granting 

requests from individuals for 

exemptions from the regulatory 

requirement regarding epilepsy found in 

§ 391.41(b)(8). 

To be considered for an exemption 

from the epilepsy and seizure disorders 

prohibition in § 391.41(b)(8), applicants 

must meet the criteria in the 2007 

recommendations of the Agency’s 

Medical Expert Panel (78 FR 3069). 

III. Qualifications of Applicants 

Michael Curtis 

Mr. Curtis is a 41-year-old a class D 

license holder in Delaware. He has a 

history of idiopathic generalized 

epilepsy and has been seizure free since 

2011. He takes anti-seizure medication 

with the dosage and frequency 

remaining the same since September 

2019. His physician states that he is 

supportive of Mr. Curtis receiving an 

exemption. 

Denise Denton 

Ms. Denton is a 50-year-old a class C 

license holder in Michigan. She has a 

history of epilepsy and has been seizure 

free since 2006. She takes anti-seizure 

medication with the dosage and 

frequency remaining the same since for 

more than 10 years. Her physician states 

that he is supportive of Ms. Denton 

receiving an exemption. 

Paul Drewer 

Mr. Drewer is a 50-year-old a CDL 

holder in Pennsylvania. He has a history 

of epilepsy and has been seizure free 

since 1999. He takes anti-seizure 

medication with the dosage and 

frequency remaining the same since 

April 2001. His physician states that he 

is supportive of Mr. Drewer receiving an 

exemption. 

Peter Guzman 

Mr. Guzman is a 74-year-old a class D 

license holder in Virginia. He has a 

history of a single unprovoked seizure 

and has been seizure free since 2008. He 

has remained off anti-seizure 

medication since November 2018. His 

physician states that he is supportive of 

Mr. Guzman receiving an exemption. 

Zachary Henson 

Mr. Henson is a 22-year-old a CDL 

holder in Illinois. He has a history of 

focal epilepsy disorder and has been 

seizure free since 2013. He takes antiseizure medication with the dosage and 

frequency remaining the same since 

October 2018. His physician states that 

he is supportive of Mr. Henson 

receiving an exemption. 

Scott Hughes 

Mr. Hughes is a 59-year-old a CDL 

holder in Illinois. He has a history of 

generalized convulsive epilepsy and has 

been seizure free since 2001. He takes 

anti-seizure medication with the dosage 

and frequency remaining the same since 

September 2003. His physician states 

that he is supportive of Mr. Hughes 

receiving an exemption. 

Scott Hunter 

Mr. Hunter is a 49-year-old class D 

license holder in Massachusetts. He has 

a history of epilepsy and has been 

seizure free since 2008. He takes antiseizure medication with the dosage and 

frequency remaining the same since 

October 2019. His physician states that 

he is supportive of Mr. Hunter receiving 

an exemption. 

Robert Lombardo 

Mr. Lombardo is a 31-year-old class C 

license holder in California. He has a 

history of epilepsy and has been seizure 

free since 2011. He takes anti-seizure 

medication with the dosage and 

frequency remaining the same since 

November 2018. His physician states 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 87, No. 63 / Friday, April 1, 2022 / Notices 19171 

that he is supportive of Mr. Lombardo 

receiving an exemption. 

Devi Thapa 

Mr. Thapa is a 45-year-old class C 

license holder in Georgia. He has a 

history of epilepsy and has been seizure 

free since 2009. He takes anti-seizure 

medication with the dosage and 

frequency remaining the same since 

2010. His physician states that he is 

supportive of Mr. Thapa receiving an 

exemption. 

IV. Request for Comments 

In accordance with 49 U.S.C. 31136(e) 

and 31315(b), FMCSA requests public 

comment from all interested persons on 

the exemption petitions described in 

this notice. We will consider all 

comments received before the close of 

business on the closing date indicated 

under the DATES section of the notice. 

Larry W. Minor, 

Associate Administrator for Policy. 

[FR Doc. 2022–06861 Filed 3–31–22; 8:45 am] 

BILLING CODE 4910–EX–P 

DEPARTMENT OF TRANSPORTATION 

Federal Motor Carrier Safety 

Administration 

[Docket No. FMCSA–2012–0332; FMCSA– 

2013–0121; FMCSA–2013–0122; FMCSA– 

2013–0123; FMCSA–2013–0124; FMCSA– 

2013–0125; FMCSA–2013–0126; FMCSA– 

2015–0325; FMCSA–2015–0327; FMCSA– 

2016–0003; FMCSA–2017–0057; FMCSA– 

2017–0059; FMCSA–2019–0111] 

Qualification of Drivers; Exemption 

Applications; Hearing 

AGENCY: Federal Motor Carrier Safety 

Administration (FMCSA), Department 

of Transportation (DOT). 

ACTION: Notice of renewal of 

exemptions; request for comments. 

SUMMARY: FMCSA announces its 

decision to renew exemptions for 31 

individuals from the hearing 

requirement in the Federal Motor 

Carrier Safety Regulations (FMCSRs) for 

interstate commercial motor vehicle 

(CMV) drivers. The exemptions enable 

these hard of hearing and deaf 

individuals to continue to operate CMVs 

in interstate commerce. 

DATES: Each group of renewed 

exemptions were applicable on the 

dates stated in the discussions below 

and will expire on the dates provided 

below. Comments must be received on 

or before May 2, 2022. 

ADDRESSES: You may submit comments 

identified by the Federal Docket 

Management System (FDMS) Docket No. 

FMCSA–2012–0332, Docket No. 

FMCSA–2013–0121, Docket No. 

FMCSA–2013–0122, Docket No. 

FMCSA–2013–0123, Docket No. 

FMCSA–2013–0124, Docket No. 

FMCSA–2013–0125, Docket No. 

FMCSA–2013–0126, Docket No. 

FMCSA–2015–0325, Docket No. 

FMCSA–2015–0327, Docket No. 

FMCSA–2016–0003, Docket No. 

FMCSA–2017–0057, Docket No. 

FMCSA–2017–0059, or Docket No. 

FMCSA–2019–0111 using any of the 

following methods: 

• Federal eRulemaking Portal: Go to 

www.regulations.gov/, insert the docket 

number, FMCSA–2012–0332, FMCSA– 

2013–0121, FMCSA–2013–0122, 

FMCSA–2013–0123, FMCSA–2013– 

0124, FMCSA–2013–0125, FMCSA– 

2013–0126, FMCSA–2015–0325, 

FMCSA–2015–0327, FMCSA–2016– 

0003, FMCSA–2017–0057, FMCSA– 

2017–0059, or FMCSA–2019–0111 in 

the keyword box, and click ‘‘Search.’’ 

Next, sort the results by ‘‘Posted 

(Newer-Older),’’ choose the first notice 

listed, and click on the ‘‘Comment’’ 

button. Follow the online instructions 

for submitting comments. 

• Mail: Dockets Operations; U.S. 

Department of Transportation, 1200 

New Jersey Avenue SE, West Building 

Ground Floor, Room W12–140, 

Washington, DC 20590–0001. 

• Hand Delivery: West Building 

Ground Floor, Room W12–140, 1200 

New Jersey Avenue SE, Washington, DC 

20590–0001, between 9 a.m. and 5 p.m., 

ET, Monday through Friday, except 

Federal Holidays. 

• Fax: (202) 493–2251. 

To avoid duplication, please use only 

one of these four methods. See the 

‘‘Public Participation’’ portion of the 

SUPPLEMENTARY INFORMATION section for 

instructions on submitting comments. 

FOR FURTHER INFORMATION CONTACT: Ms. 

Christine A. Hydock, Chief, Medical 

Programs Division, (202) 366–4001, 

fmcsamedical@dot.gov, FMCSA, DOT, 

1200 New Jersey Avenue SE, Room 

W64–224, Washington, DC 20590–0001. 

Office hours are from 8:30 a.m. to 5 

p.m., ET, Monday through Friday, 

except Federal holidays. If you have 

questions regarding viewing or 

submitting material to the docket, 

contact Dockets Operations, (202) 366– 

9826. 

SUPPLEMENTARY INFORMATION: 

I. Public Participation 

A. Submitting Comments 

If you submit a comment, please 

include the docket number for this 

notice (Docket No. FMCSA–2012–0332, 

Docket No. FMCSA–2013–0121, Docket 

No. FMCSA–2013–0122, Docket No. 

FMCSA–2013–0123, Docket No. 

FMCSA–2013–0124, Docket No. 

FMCSA–2013–0125, Docket No. 

FMCSA–2013–0126, Docket No. 

FMCSA–2015–0325, Docket No. 

FMCSA–2015–0327, Docket No. 

FMCSA–2016–0003, Docket No. 

FMCSA–2017–0057, Docket No. 

FMCSA–2017–0059, or Docket No. 

FMCSA–2019–0111), indicate the 

specific section of this document to 

which each comment applies, and 

provide a reason for each suggestion or 

recommendation. You may submit your 

comments and material online or by fax, 

mail, or hand delivery, but please use 

only one of these means. FMCSA 

recommends that you include your 

name and a mailing address, an email 

address, or a phone number in the body 

of your document so that FMCSA can 

contact you if there are questions 

regarding your submission. 

To submit your comment online, go to 

www.regulations.gov/, insert the docket 

number, FMCSA–2012–0332, FMCSA– 

2013–0121, FMCSA–2013–0122, 

FMCSA–2013–0123, FMCSA–2013– 

0124, FMCSA–2013–0125, FMCSA– 

2013–0126, FMCSA–2015–0325, 

FMCSA–2015–0327, FMCSA–2016– 

0003, FMCSA–2017–0057, FMCSA– 

2017–0059, or FMCSA–2019–0111 in 

the keyword box, and click ‘‘Search.’’ 

Next, sort the results by ‘‘Posted 

(Newer-Older),’’ choose the first notice 

listed, click the ‘‘Comment’’ button, and 

type your comment into the text box on 

the following screen. Choose whether 

you are submitting your comment as an 

individual or on behalf of a third party 

and then submit. 

If you submit your comments by mail 

or hand delivery, submit them in an 

unbound format, no larger than 81⁄2 by 

11 inches, suitable for copying and 

electronic filing. If you submit 

comments by mail and would like to 

know that they reached the facility, 

please enclose a stamped, self-addressed 

postcard or envelope. 

FMCSA will consider all comments 

and material received during the 

comment period. 

B. Viewing Comments 

To view comments go to 

www.regulations.gov. Insert the docket 

number, FMCSA–2012–0332, FMCSA– 

2013–0121, FMCSA–2013–0122, 

FMCSA–2013–0123, FMCSA–2013– 

0124, FMCSA–2013–0125, FMCSA– 

2013–0126, FMCSA–2015–0325, 

FMCSA–2015–0327, FMCSA–2016– 

0003, FMCSA–2017–0057, FMCSA– 

2017–0059, or FMCSA–2019–0111 in 

the keyword box, and click ‘‘Search.’’ 

Next, sort the results by ‘‘Posted 


lotter on DSK11XQN23PROD with NOTICES1